Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Aaron Paul Provenzano"'
Autor:
Santosh Kesari, Andrew Brenner, Joanne Xiu, Surasak Phuphanich, Sandeep Mittal, Deepa S. Subramaniam, W. Michael Korn, Amy B. Heimberger, David Spetzler, Ashley Sumrall, Majari Pandey, Zoran Gatalica, Aaron Paul Provenzano
BACKGROUND: PD-1 and PD-L1 expression has not been well-described in PCNSL. In one report of 20 PCNSL tumors, PD-1 and PD-L1 expression on tumor cells (TC), tumor-infiltrating lymphocytes (TIL), or tumor-associated macrophages (TAM) was seen in 90% (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9f07cbdd172d54f1a2add06d2012a77
https://europepmc.org/articles/PMC6217688/
https://europepmc.org/articles/PMC6217688/
Autor:
Ashley Love Sumrall, Sharon K. Michelhaugh, Aaron Paul Provenzano, Joanne Xiu, Santosh Kesari, Manjari Pandey, Sandeep Mittal, Deepa S. Subramaniam, Michael Gary Martin, Andrew Brenner, W. Michael Korn, Amy B. Heimberger, Surasak Phuphanich, Matthew K Stein
Publikováno v:
Journal of Clinical Oncology. 36:2067-2067
2067Background: Up to 40% of LADC patients (pts) develop BM but little is known about the inciting molecular events. Methods: We compared mutational profiles of LADC BM pts with primary (P) LADC su...
Publikováno v:
Expert review of anticancer therapy. 13(2)
Overcoming endocrine resistance is a 21st century hurdle in the treatment of hormone receptor-positive breast cancers. Estrogen plays a role in the growth of 70% of breast cancers. There are many strategies evolved to overcome estrogen resistance. Es
Autor:
Govardhanan Nagaiah, Sijin Wen, Farhad Khimani, Aaron Paul Provenzano, Manish Monga, Sobha Kurian, Miklos L Auber, Zachary Zinn, Mohammed Almubarak, Scot C. Remick, Quoc Truong, Brendan F. Curley
Publikováno v:
Journal of Clinical Oncology. 32:e17037-e17037
e17037 Background: Acneform rash is associated with cetuximab, can be treatment limiting and has been shown to correlate with tumor response. The rash is thought to have an inflammatory component t...